Article

December 10, 2012

Ralph M. Meyer, MD, Compares the Role of Radiation Therapy to Conventional Management Strategies in Patients With Hodgkin's Lymphoma

Ralph M. Meyer, MD, Director of Clinical Trials Group, National Cancer Institute of Canada, Queen's University, offers a counterpoint to the thoughts of Richard T. Hoppe, MD, on the role and utility of radiation therapy in patients with early stage Hodgkin's lymphoma.

Ralph M. Meyer, MD, Director of Clinical Trials Group, National Cancer Institute of Canada, Queen's University, offers a counterpoint to the thoughts of Richard T. Hoppe, MD, on the role and utility of radiation therapy in patients with early stage Hodgkin's lymphoma. He compares the clinical outcomes associated with the use of radiation therapy and conventional treatment regimens.

This video was taken on Monday, December 10, at the American Society of Hematology's 54th Annual Meeting in Atlanta, GA.

Related Videos

IMS Recap

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel

Screenshot during an interview with Aaron Adkisson, PharmD

Binod Dhakal, MD.

Ashraf Badros, MB, ChB.

Saad Z Usmani, MD, MBA, FACP.

Rahul Banerjee, MD, FACP

Anant Madabhushi, PhD.

Rahul Banerjee, MD, FACP.

Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division

Related Content

CAR T-cell therapy | Image credit: Getty Images

October 2nd 2024

Coming Soon: An Off-the-Shelf CAR T Therapy for Myeloma

Attendees at the International Myeloma Society 21st Annual Meeting & Exposition got an early look at data for an investigational allogeneic chimeric antigen receptor (CAR) T-cell product from healthy donor cells to prevent graft-versus-host disease.

August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.

Ajai Chari, MD | Image credit: UCSF

October 1st 2024

From CARs to Trispecifics, More Choices to Come in Multiple Myeloma

Ajai Chari, MD, covered both recent FDA approvals and pipeline products, such as non-BCMA chimeric antigen receptor (CAR) T-cell therapies and trispecifics, during a symposium on Immunotherapy at the International Myeloma Society 21st Annual Meeting & Exposition.

Managed Care Cast.

June 28th 2022

Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

Matthew Gavidia

On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.

Lucio N. Gordan, MD | Image credit: Florida Cancer Specialists & Research Institute

October 1st 2024

How Do Community Oncologists View the Use of MRD Testing?

Investigators from Florida Cancer Specialists & Research Institute explored questions surrounding minimal residual disease (MRD) negativity testing in an abstract presented at the International Myeloma Society 21st Annual Meeting & Exposition.

Screenshot of Akshay Desai, MD, of Brigham & Women’s Hospital, during a video interview

September 29th 2024

Efficacy of Finerenone Around Recent Worsening Heart Failure

Laura Joszt, MA

Finerenone is at least as effective in patients who are in the hospital or were recently hospitalized for heart failure as those with stable condition, said Akshay Desai, MD, of Brigham & Women’s Hospital.

Related Content

CAR T-cell therapy | Image credit: Getty Images

October 2nd 2024

Coming Soon: An Off-the-Shelf CAR T Therapy for Myeloma

Attendees at the International Myeloma Society 21st Annual Meeting & Exposition got an early look at data for an investigational allogeneic chimeric antigen receptor (CAR) T-cell product from healthy donor cells to prevent graft-versus-host disease.

August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.

Ajai Chari, MD | Image credit: UCSF

October 1st 2024

From CARs to Trispecifics, More Choices to Come in Multiple Myeloma

Ajai Chari, MD, covered both recent FDA approvals and pipeline products, such as non-BCMA chimeric antigen receptor (CAR) T-cell therapies and trispecifics, during a symposium on Immunotherapy at the International Myeloma Society 21st Annual Meeting & Exposition.

Managed Care Cast.

June 28th 2022

Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

Matthew Gavidia

On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.

Lucio N. Gordan, MD | Image credit: Florida Cancer Specialists & Research Institute

October 1st 2024

How Do Community Oncologists View the Use of MRD Testing?

Investigators from Florida Cancer Specialists & Research Institute explored questions surrounding minimal residual disease (MRD) negativity testing in an abstract presented at the International Myeloma Society 21st Annual Meeting & Exposition.

Screenshot of Akshay Desai, MD, of Brigham & Women’s Hospital, during a video interview

September 29th 2024

Efficacy of Finerenone Around Recent Worsening Heart Failure

Laura Joszt, MA

Finerenone is at least as effective in patients who are in the hospital or were recently hospitalized for heart failure as those with stable condition, said Akshay Desai, MD, of Brigham & Women’s Hospital.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions